[go: up one dir, main page]

MD2551G2 - Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses - Google Patents

Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses Download PDF

Info

Publication number
MD2551G2
MD2551G2 MDA20030280A MD20030280A MD2551G2 MD 2551 G2 MD2551 G2 MD 2551G2 MD A20030280 A MDA20030280 A MD A20030280A MD 20030280 A MD20030280 A MD 20030280A MD 2551 G2 MD2551 G2 MD 2551G2
Authority
MD
Moldova
Prior art keywords
mycoses
treatment
pharmaceutically acceptable
oral cavity
ozonized
Prior art date
Application number
MDA20030280A
Other languages
Romanian (ro)
Russian (ru)
Inventor
Андрей ПЫРГАРЬ
Борис ПЫРГАРЬ
Original Assignee
Андрей ПЫРГАРЬ
Борис ПЫРГАРЬ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Андрей ПЫРГАРЬ, Борис ПЫРГАРЬ filed Critical Андрей ПЫРГАРЬ
Priority to MDA20030280A priority Critical patent/MD2551G2/en
Publication of MD2551G2 publication Critical patent/MD2551G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention refers to medicine, in particular to stomatology.Summary of the invention consists in using pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses.
MDA20030280A 2003-12-03 2003-12-03 Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses MD2551G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20030280A MD2551G2 (en) 2003-12-03 2003-12-03 Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20030280A MD2551G2 (en) 2003-12-03 2003-12-03 Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses

Publications (1)

Publication Number Publication Date
MD2551G2 true MD2551G2 (en) 2005-03-31

Family

ID=62129620

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20030280A MD2551G2 (en) 2003-12-03 2003-12-03 Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses

Country Status (1)

Country Link
MD (1) MD2551G2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2123319C1 (en) * 1996-12-24 1998-12-20 Нижегородская государственная медицинская академия Method of treating inflammatory diseases of parodontium
MD2354F1 (en) * 2003-07-29 2004-01-31 Boris Pirgari Method of treatment of the hepatic encephalopathy
MD2375F1 (en) * 2003-07-29 2004-02-29 Constantin Tibirna Method of portal gastropathy treatment in hepatic cirrhosis
MD2327G2 (en) * 2003-07-11 2004-07-31 Андрей ПЫРГАРЬ Method of treatment of parodontium affections

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2123319C1 (en) * 1996-12-24 1998-12-20 Нижегородская государственная медицинская академия Method of treating inflammatory diseases of parodontium
MD2327G2 (en) * 2003-07-11 2004-07-31 Андрей ПЫРГАРЬ Method of treatment of parodontium affections
MD2354F1 (en) * 2003-07-29 2004-01-31 Boris Pirgari Method of treatment of the hepatic encephalopathy
MD2375F1 (en) * 2003-07-29 2004-02-29 Constantin Tibirna Method of portal gastropathy treatment in hepatic cirrhosis

Similar Documents

Publication Publication Date Title
MXPA04003666A (en) Use of flibanserin in the treatment of sexual disorders.
TW200505881A (en) Tri(cyclo) substituted amide compounds
IL176452A0 (en) Effervescent oral opiate dosage form
TW200500358A (en) Compounds
PL1654253T3 (en) Substituted 3-pyrrolidin-indole derivatives
WO2002088100A3 (en) Deuterated 3-piperidinopropiophenone and medicaments containing said compounds
MEP55308A (en) New pharmaceutical compositions containing flibanserin polymorph a
SG148194A1 (en) Compositions for the treatment of affections of the oral cavity and upper respiratory tract
IL171974A0 (en) Tetrahydrocarbazole derivatives and their pharmaceutical use
AU2003272317A1 (en) Treatment of periodontal disease with photosensitizers
EA200702522A1 (en) SYSTEM OF DELIVERY OF MEDICINES IN THE CAVITY OF THE MOUTH AND METHODS OF ITS APPLICATION
TW200716204A (en) Pharmaceutical composition
GR20020100478A (en) Anhydrous crystalline valaciclivier hydrochloride
UA83821C2 (en) Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain
TW200509992A (en) Dosage form containing pantoprazole as active ingredient
MXPA05014184A (en) Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas.
IL172423A0 (en) Novel formulations for opioid -based treatments of pain comprising substituted 1,4-di-piperidin-4-yl-piperazine derivatives
UA85685C2 (en) Use of quinolone antibiotics for controlling bacterial diseases of oral cavity
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
UA86399C2 (en) Normal;heading 1;heading 2;USE OF 2,5-DIHYDROXYBENZENESULPHONIC ACID IN THE PRODUCTION OF MEDICAMENTS FOR THE TREATMENT OF ANGIODEPENDENT DISEASES
MX260260B (en) Semi-solid formulations for the oral administration of taxoids.
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
AP2006003613A0 (en) Oral formulations for 5-HT-receptor agonists, usesand methods of treatment employing the same
MD2551G2 (en) Use of pharmaceutically acceptable ozonized solutions for treatment of oral cavity mycoses
MXPA05007253A (en) Novel anticonvulsant derivative salts.

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees